Tag: manufacturing defects

Investigation of Assay Degradation Trends Post-Market Storage Pharmaceutical companies often face challenges related to assay degradation after products have been stored in the market. This degradation can lead to Out…

Dissolution Slowdown in Extended Shelf-Life Products: A Practical Investigation Framework The pharmaceutical industry often faces challenges with product performance as it relates to stability over time. A common issue encountered…

Analyzing pH Drift in Products After Market Storage: Investigating CAPA and Shelf-Life Justification Gaps In pharmaceutical manufacturing, maintaining product integrity post-market storage is critical. A typical issue that surfaces is…

Investigating Assay Degradation Trends in Accelerated Conditions: A Path to Regulatory Inspection Readiness The stability of pharmaceutical products is crucial to ensure efficacy, safety, and compliance with regulatory standards. Recently,…

Investigating Preservative Loss After Market Storage: Mitigating Regulatory Inspection Risks In the pharmaceutical industry, the stability of products post-manufacturing and during market storage is paramount. A significant concern arises when…

Investigation of Preservative Loss After Market Storage: CAPA and Shelf-Life Justification In the highly regulated pharmaceutical industry, the stability of products post-manufacturing is paramount. One pressing issue that can arise…

Understanding Packaging Ingress Failures Post-Market Storage: A Comprehensive Investigation Packaging ingress failures pose significant challenges for pharmaceutical manufacturers, particularly after a product has been stored in the market environment. These…

Investigating Changes in Physical Appearance During Shelf-life Extension: Regulatory Risks and Solutions In the pharmaceutical industry, maintaining product integrity throughout its shelf life is paramount. When alterations in physical appearance…

Dissolution Slowdown at Accelerated Conditions: Managing Regulatory Inspection Risks In the highly regulated pharmaceutical industry, issues concerning dissolution profiles can have serious implications. A common problem encountered in stability testing…

Analyzing pH Drift During Long-Term Stability Storage: A Comprehensive Investigation Approach pH drift observed during long-term stability storage can pose a significant regulatory inspection risk for pharmaceutical manufacturers. Such deviations…

Investigating pH Drift During Storage for Shelf-Life Extension: A Regulatory Focus In pharmaceutical manufacturing, detecting a pH drift during storage, especially during shelf-life extension, poses significant regulatory inspection risks. This…

Dissolution Slowing at Accelerated Conditions: An Investigation Guide In the realm of pharmaceutical manufacturing, the occurrence of a dissolution slowdown at accelerated conditions represents a critical quality issue that may…